| Group A | Group B | Group C | p value | Post Hoc Bonferroni test (p) | ||
---|---|---|---|---|---|---|---|
AvsC | AvsB | BvsC | |||||
Peak systolic longitudinal strain (%) | |||||||
 Endo | − 22.8 ± 0.4a | − 24.7 ± 0.4 | − 25.5 ± 0.5 |  < 0.001 | 0.001 | 0.023 | 1.000 |
 Mid | − 19.7 ± 0.3 | − 21.1 ± 0.4 | − 22.1 ± 0.4 |  < 0.001 | 0.001 | 0.075 | 0.577 |
 Epi | − 17.4 ± 0.3 | − 18.8 ± 0.3 | − 19.3 ± 0.4 | 0.001 | 0.002 | 0.042 | 1.000 |
Peak systolic circumferential strain (%) | |||||||
 Basal LV level | |||||||
  Endo | − 20.0 ± 0.8 | − 23.2 ± 1.2 | − 24.2 ± 1.1 | 0.010 | 0.023 | 0.127 | 1.000 |
  Mid | − 13.8 ± 0.6 | − 16.5 ± 0.9 | − 17.4 ± 0.9 | 0.002 | 0.005 | 0.043 | 1.000 |
  Epi | − 9.5 ± 0.4 | − 11.3 ± 0.6 | − 12.8 ± 0.8 |  < 0.001 |  < 0.001 | 0.091 | 0.442 |
 Mid-cavity LV level | |||||||
  Endo | − 27.6 ± 0.9 | − 29.1 ± 1.0 | − 29.2 ± 1.1 | 0.499 | – | – | – |
  Mid | − 19.5 ± 0.7 | − 20.7 ± 0.7 | − 21.4 ± 1.0 | 0.262 | – | – | – |
  Epi | − 13.5 ± 0.5 | − 15.1 ± 0.6 | − 16.0 ± 1.0 | 0.038 | 0.049 | 0.393 | 1.000 |
 Apical LV level | |||||||
  Endo | − 35.7 ± 1.0 | − 34.1 ± 1.7 | − 35.5 ± 1.6 | 0.713 | – | – | – |
  Mid | − 26.9 ± 0.8 | − 25.6 ± 1.4 | − 26.8 ± 1.4 | 0.727 | – | – | – |
  Epi | − 20.7 ± 0.7 | − 18.9 ± 1.3 | − 20.9 ± 1.3 | 0.461 | – | – | – |